-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| S658493 | 1185883-40-2 | (4S)-3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基)氨基](4-羟基苯基)甲基]-5-羟基-1-氧代戊基]-4-苯基-2-恶唑烷酮, 95% (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone, 95% |
C33H30F2N2O5 | |
| F657385 | 1425938-63-1 | (4S)-3-[(2S,3R)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸, 98% Fmoc-Thr(tBu)-Ser[Psi(Me,Me)Pro]-OH, 98% |
C29H36N2O7 | |
| S831383 | 189028-93-1 | (4S)-3-[5-(4-氟苯基)-1,5-二氧代戊基]-4-苯基-2-恶唑烷酮, 98% (S)-4-Phenyl-3-[5-(4-fluorophenyl)-5-oxopentanoyl]-2-oxazolidinone, 98% |
C20H18FNO4 | |
| S929498 | 178327-18-9 | (4S)-4-Benzyl-3-[[(1S,2R)-2-hydroxy-3-cyclopenten-1-yl]carbonyl]-1,3-oxazolidin-2-one, 95% (4S)-4-Benzyl-3-[[(1S,2R)-2-hydroxy-3-cyclopenten-1-yl]carbonyl]-1,3-oxazolidin-2-one, 95% |
C16H17NO4 | |
| L919621 | 90719-30-5 | (4S)-N-巴豆酰基-4-异丙基-2-恶唑烷酮, 98% (HPLC) Locostatin (s,e)-4-benzyl-3-(but-2-enoyl)oxazolidin-2-one, 98% (HPLC) |
C14H15NO3 | |
| S965930 | 477351-96-5 | (4S, 4'S)-2, 2'-(4-溴吡啶-2, 6-二基)双(4-异丙基-4, 5-二氢恶唑), 98% (4S, 4'S)-2, 2'-(4-Bromopyridine-2, 6-diyl)bis(4-isopropyl-4, 5-dihydrooxazole), 98% |
C17H22BrN3O2 | |
| S783729 | 2757083-13-7 | (4S,4'S)-2,2'-((苯基膦二基)双(2,1-亚苯基))双(4-((S)-仲丁基)-4,5-二氢恶唑), 97% (4S,4'S)-2,2'-((Phenylphosphanediyl)bis(2,1-phenylene))bis(4-((S)-sec-butyl)-4,5-dihydrooxazole), 97% |
C32H37N2O2P | |
| S993351 | 2757082-01-0 | (4S,4'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4-异丙基噁唑], 97% (4S,4'S)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 97% |
C21H28N2O2 | |
| S780691 | 2757085-43-9 | (4S,4'S)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(4-苄基-4,5-二氢恶唑), 97% (4S,4'S)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(4-benzyl-4,5-dihydrooxazole), 97% |
C55H62N2O2 | |
| S783862 | 2248620-13-3 | (4S,4'S)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(4-苯基-4,5-二氢恶唑), 97% (4S,4'S)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97% |
C53H58N2O2 | |
| S743208 | 2253165-17-0 | (4S,4'S)-2,2'-(丙烷-2,2-二基)双(4,5,5-三苯基-4,5-二氢恶唑), 95% (4S,4'S)-2,2'-(Propane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole), 95% |
C45H38N2O2 | |
| S748737 | 2328084-27-9 | (4S,4'S)-2,2'-(环丙烷-1,1-二基)双(4,5-二氢恶唑-4-羧酸)二叔丁酯, 95% (4S,4'S)-Di-tert-butyl 2,2'-(cyclopropane-1,1-diyl)bis(4,5-dihydrooxazole-4-carboxylate), 95% |
C19H28N2O6 | |
| S994632 | 2828432-04-6 | (4S,4'S)-2,2'-(环庚烷-1,1-二基)双(4-异丙基-4,5-二氢噁唑), 97% (4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 97% |
C19H32N2O2 | |
| S989888 | 2757082-25-8 | (4S,4'S)-2,2'-(环庚烷-1,1-二基)双(4-苄基-4,5-二氢噁唑), 97% (4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-benzyl-4,5-dihydrooxazole), 97% |
C27H32N2O2 | |
| S753231 | 2094476-37-4 | (4S,4'S)-4,4'-二(庚基-4-基)-4,4',5,5'-四氢-2,2'-联恶唑, 97% (4S,4'S)-4,4'-Di(heptan-4-yl)-4,4',5,5'-tetrahydro-2,2'-bioxazole, 97% |
C20H36N2O2 | |
| S780860 | 2582969-66-0 | (4S,4'S,5R,5'R)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(4,5二苯基-4,5-二氢恶唑), 97% (4S,4'S,5R,5'R)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole), 97% |
C65H66N2O2 | |
| S747927 | 158722-22-6 | (4S,5R)-2,4-二苯基-4,5-二氢恶唑-5-羧酸, 95% (4S,5R)-2,4-Diphenyl-4,5-dihydrooxazole-5-carboxylicacid, 95% |
C16H13NO3 | |
| S746112 | 2828438-17-9 | (4S,5R)-2-(1,10-菲咯啉-2-基)-4,5-二苯基-4,5-二氢恶唑, 98% (4S,5R)-2-(1,10-Phenanthrolin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 98% |
C27H19N3O | |
| S747677 | 2828432-21-7 | (4S,5R)-2-(1,8-萘啶-2-基)-4,5-二苯基-4,5-二氢恶唑, 97% (4S,5R)-2-(1,8-Naphthyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97% |
C23H17N3O | |
| S921633 | 957780-52-8 | (4S,5R)-3-((((9H-芴-9-基)甲氧基)羰基)-L异亮氨酰)-2,2,5-三甲基恶唑烷-4-羧酸, 98% (4S,5R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)-L-isoleucyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98% |
C28H34N2O6 |
